205 related articles for article (PubMed ID: 2775377)
1. Extended experience with surgical treatment of stage D1 adenocarcinoma of prostate. Significant influences of immediate adjuvant hormonal treatment (orchiectomy) on outcome.
Zincke H
Urology; 1989 May; 33(5 Suppl):27-36. PubMed ID: 2775377
[TBL] [Abstract][Full Text] [Related]
2. Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors.
Zincke H; Bergstralh EJ; Larson-Keller JJ; Farrow GM; Myers RP; Lieber MM; Barrett DM; Rife CC; Gonchoroff NJ
Cancer; 1992 Jul; 70(1 Suppl):311-23. PubMed ID: 1600493
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome in patients with pTxN+ adenocarcinoma of prostate treated with radical prostatectomy and early androgen ablation.
Seay TM; Blute ML; Zincke H
J Urol; 1998 Feb; 159(2):357-64. PubMed ID: 9649239
[TBL] [Abstract][Full Text] [Related]
4. Bilateral pelvic lymphadenectomy and radical prostatectomy for clinical stage C prostatic cancer: role of adjuvant treatment for residual cancer and in disease progression.
Zincke H; Utz DC; Taylor WF
J Urol; 1986 Jun; 135(6):1199-205. PubMed ID: 3086572
[TBL] [Abstract][Full Text] [Related]
5. Combined surgery and immediate adjuvant hormonal treatment for stage D1 adenocarcinoma of the prostate: Mayo Clinic experience.
Zincke H
Semin Urol; 1990 Aug; 8(3):175-83. PubMed ID: 2399386
[No Abstract] [Full Text] [Related]
6. Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy.
Hawkins CA; Bergstralh EJ; Lieber MM; Zincke H
Urology; 1995 Sep; 46(3):356-64. PubMed ID: 7544934
[TBL] [Abstract][Full Text] [Related]
7. Observations on surgical management of carcinoma of prostate with limited nodal metastases.
Zincke H; Utz DC
Urology; 1984 Aug; 24(2):137-45. PubMed ID: 6464250
[TBL] [Abstract][Full Text] [Related]
8. Early endocrine therapy versus radical prostatectomy combined with early endocrine therapy for stage D1 prostate cancer.
Schmeller N; Lubos W
Br J Urol; 1997 Feb; 79(2):226-34. PubMed ID: 9052475
[TBL] [Abstract][Full Text] [Related]
9. Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for stage C or D1 adenocarcinoma of the prostate: possible beneficial effect of adjuvant treatment.
Zincke H
NCI Monogr; 1988; (7):109-15. PubMed ID: 3173496
[TBL] [Abstract][Full Text] [Related]
10. Radical prostatectomy for pathologic stage C prostate cancer: influence of pathologic variables and adjuvant treatment on disease outcome.
Cheng WS; Frydenberg M; Bergstralh EJ; Larson-Keller JJ; Zincke H
Urology; 1993 Sep; 42(3):283-91. PubMed ID: 8379028
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant radiotherapy following radical prostatectomy--results of 56 patients.
Wiegel T; Bressel M; Carl UM
Eur J Cancer; 1995; 31A(1):5-11. PubMed ID: 7535075
[TBL] [Abstract][Full Text] [Related]
12. Treatment options for patients with stage D1 (T0-3,N1-2,M0) adenocarcinoma of prostate.
Zincke H; Utz DC; Thulé PM; Taylor WF
Urology; 1987 Oct; 30(4):307-15. PubMed ID: 3660520
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant radiation, chemotherapy, and androgen deprivation therapy for pathologic stage D1 adenocarcinoma of the prostate.
Freeman JA; Lieskovsky G; Grossfeld G; Esrig D; Stein JP; Cook DW; Petrovich Z; Chen SC; Groshen S; Skinner DG
Urology; 1994 Nov; 44(5):719-25. PubMed ID: 7526528
[TBL] [Abstract][Full Text] [Related]
14. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer.
Messing EM; Manola J; Sarosdy M; Wilding G; Crawford ED; Trump D
N Engl J Med; 1999 Dec; 341(24):1781-8. PubMed ID: 10588962
[TBL] [Abstract][Full Text] [Related]
15. Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis.
Montgomery BT; Nativ O; Blute ML; Farrow GM; Myers RP; Zincke H; Therneau TM; Lieber MM
Arch Surg; 1990 Mar; 125(3):327-31. PubMed ID: 2306181
[TBL] [Abstract][Full Text] [Related]
16. Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer.
Zincke H; Lau W; Bergstralh E; Blute ML
J Urol; 2001 Dec; 166(6):2208-15. PubMed ID: 11696737
[TBL] [Abstract][Full Text] [Related]
17. Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for Stage C adenocarcinoma of prostate.
Zincke H; Utz DC; Benson RC; Patterson DE
Urology; 1984 Dec; 24(6):532-9. PubMed ID: 6506391
[TBL] [Abstract][Full Text] [Related]
18. The role of pathologic variables and hormonal treatment after radical prostatectomy for stage D1 disease.
Zincke H
Oncology (Williston Park); 1991 Mar; 5(3):129-39; discussion 139-40, 142. PubMed ID: 1829940
[TBL] [Abstract][Full Text] [Related]
19. Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: influence of tumor deoxyribonucleic acid ploidy.
Blute ML; Nativ O; Zincke H; Farrow GM; Therneau T; Lieber MM
J Urol; 1989 Nov; 142(5):1262-5. PubMed ID: 2810503
[TBL] [Abstract][Full Text] [Related]
20. [Adjuvant radiotherapy following radical prostatectomy--results, acute and late toxicity].
Wiegel T; Bressel M; Baumann M; Schwarz R; Hübener KH
Strahlenther Onkol; 1993 Mar; 169(3):152-8. PubMed ID: 8465249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
